Evidence map›Paper›PMID 38216978›Full record

ArticleArchives of public health = Archives belges de sante publique2024

Comparative analysis of COVID-19 and influenza prevalence among Egyptian pilgrims returning from Hajj and Umrah in 2022: epidemiology, clinical characteristics, and genomic sequencing.

Amr Kandeel, Manal Fahim, Ola Deghedy, Hala BahaaEldin, Wael H Roshdy, Mohamed Kamal Khalifa, Ahmed Kandeil, Rabeh El Shesheny, Amel Naguib, Mohamad AbdelFatah and 2 more

Abstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amr KandeelPreventive Sector, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0003-4358-7182
Manal FahimDepartment of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0002-7206-4818
Ola DeghedyDepartment of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0001-5022-5484
Hala BahaaEldinDepartment of Epidemiology and Surveillance, Preventive Sector, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt. halaaabahaa@gmail.com.ORCID http://orcid.org/0000-0002-8042-414X
Wael H RoshdyCentral Public Health Laboratory, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0001-8412-3128
Mohamed Kamal KhalifaCentral Public Health Laboratory, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.
Ahmed KandeilCentre of Scientific Excellence for Influenza Viruses, National Research Centre, 12622 Dokki, Giza, Egypt.
Rabeh El SheshenyCentre of Scientific Excellence for Influenza Viruses, National Research Centre, 12622 Dokki, Giza, Egypt.
Amel NaguibCentral Public Health Laboratory, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0002-3384-2891
Mohamad AbdelFatahPreventive Sector, Ministry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0001-9701-0333
Salma AfifiMinistry of Health and Population Consultant, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0001-7705-5999
Khaled Abdel GhaffarMinistry of Health and Population, Governmental District, New Administrative Capital, Cairo, Egypt.ORCID http://orcid.org/0000-0002-3128-0557

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the changes that occurred in the SARS-CoV-2 and influenza Prevalence, epidemiology, clinical picture, and prevalent genotypes among the Egyptian pilgrims returning from Hajj and Umrah 2022 seasons.

methodsPilgrims were contacted at the airport and invited to participate in the survey. Pilgrims who consented were interviewed using a standardized line list that included participant demographics, respiratory symptoms if any, previous COVID-19 infection, influenza vaccination whereas COVID-19 vaccination information were collected from vaccination cards. Participants were asked to provide throat and nasopharyngeal swabs for SARS-CoV-2 and influenza testing using RT-PCR and a subset of isolates were sequenced. Descriptive data analysis was performed to describe the epidemiology and clinical symptoms of SARS-CoV-2 and influenza. Prevalence rates of SARS-CoV-2 and influenza during Hajj were calculated and compared to Umrah surveys using chi

resultsOverall, 3,862 Egyptian pilgrims enrolled, their mean age was 50.5 ± 47 years, half of them were > 50 years of age and 58.2% were males. Of them, 384 (9.9%) tested positive for SARS-CoV-2 and 51 (1.3%) for influenza viruses. Prevalence of SARS-CoV-2 infections (vaccine breakthrough) increased significantly between the Umrah and Hajj surveys (6.7% vs. 9.9%, p < 0.001), and variants of the virus varied considerably. Whereas no significant difference was found in influenza prevalence, vaccine coverage and vaccine breakthrough infection rates (11.7 vs. 9.2%, 26.9 vs. 26.8%, and 1.4 vs. 1.1% respectively).

conclusionsSARS-CoV-2 prevalence among Egyptian pilgrims returning from Hajj in July increased with reduced vaccine effectiveness compared to Umrah in March 2022 suggesting a possible wave of SARS-CoV-2 in the upcoming winter.

Indexed as

Breakthrough InfectionCOVID-19Influenza AInfluenza BSARS-CoV-2Vaccine effectiveness

Identifiers

PMID38216978
PMCPMC10785524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.